Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy - A longitudinal study

British Journal of Cancer

Volumn 92, Issue 4, 2005, Pages 673-680

  Harvie, M N ^a   Howell, A ^a   Thatcher, N ^a   Baildam, A ^b   Campbell, I ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Acute phase protein response; Body composition; Chemotherapy; Energy balance; Longitudinal; Metastatic

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; IBUPROFEN; MEGESTROL ACETATE; PREDNISOLONE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BREAST METASTASIS; CALORIC INTAKE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY BALANCE; FEMALE; HUMAN; LONGITUDINAL STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTAKE; BASAL METABOLIC RATE; BREAST TUMOR; ENERGY METABOLISM; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; SKIN TUMOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BASAL METABOLISM; BODY COMPOSITION; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MELANOMA; PROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 14944361304     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602357     Document Type: Article

References (56)

1. Aaesebo U, Bremnes RM, Aakvaag A, Slordal L (1991) Gonadal endocrine dysfunction in patients with lung cancer: relation to responsiveness to chemotherapy, respiratory function and performance status. J Steroid Biochem Mol Biol 39: 375-380
2. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, Tisdale MJ, Trayhurn P (2004) Zinc-alpha2-glycoprotein, a lipid-mobilizing factor, is expressed in adipocytes and is up regulated in mice with cancer cachexia. Proc Natl Acad Sc USA 101: 2500-2505
3. Boddy K, King PC, Tothill P, Strong JA (1971) Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors. Phys Med Biol 16: 275-282
4. Borugian MJ, Sheps SB, Kim-Sing C, Olivotto IA, Van Patten C, Dunn BP, Coldman AJ, Potter JD, Gallagher RP, Hislop TG (2003) Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 158: 963-968
5. Bosaeus I, Daneryd P, Svanberg E, Lundholm K (2001) Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patient. Int J Cancer 93: 380-383
6. Bozzetti F, Migliavacca S, Scotti A, Bonalumi MG, Scarpa D, Battici F, Ammatuna M, Pupa A, Terno G, Sequeira C, Masserini C, Emanuelli H (1981) Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 96: 170-179
7. Buccheri G, Ferrigno D (2001) Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer 34: 433-440
8. Burkinshaw L (1990) Some aspects of body composition in cancer. Infusions Ther 17(Suppl 3): 57-58
9. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11: 570-579
10. Cohn SH, Vartsky D, Vaswani AN, Sawitsky A, Rai K, Gartenhaus W, Yasumura S, Ellis KJ. (1982) Changes in body composition of cancer patients following combined nutritional support. Nutr Cancer 4: 107-119
11. Coleman EA, Coon S, Hall-Barrow J, Richards K, Gaylor D, Stewart B (2003) Feasibility of exercise during treatment for multiple myeloma. Cancer Nurs 26: 410-449
12. DeWys WD, Begg C, Band P, Tormey D (1981) The impact of malnutrition on treatment results in breast cancer. Cancer Treat Rep 65(Suppl 5): 87-91
13. Durnin JV, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16-72 years. Br J Nutr 32: 77-97
14. Evans WK, Nixon DW, Daly JM, Ellenberg SS, Gardner L, Wolfe E, Shepherd FA, Feld R, Gralla R, Fine S (1987) A randomised study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small cell lung cancer. J Clin Oncol 5: 113-124
15. Fearon KC, Von Meyenfeldt MF, Moses AG, Van Geenen R, Roy A, Gouma DJ, Giacosa A, Van Gossum A, Bauer J, Barber MD, Aaronson NK, Voss AC, Tisdale MJ (2003) Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52: 1479-1486
16. Garrow JS (1974) Energy stores: their composition measurement and control. In Energy Balance and Obesity in Man pp 177-224. Amsterdam: North-Holland
17. Grindel CG, Cahill CA, Walker M (1989) Food intake of women with breast cancer during their first 6 months of chemotherapy. Oncol Nurs Forum 16: 401-407
18. Gurney JM, Jelliffe DB (1973) Arm anthropometry in nutritional assessment: nomogram for rapid calculation of muscle circumference and cross-sectional muscle and fat areas. Am J Clin Nutr 26: 912-915
19. Harris JA, Benedict FG (1919) In a Biometric Study of Basal Metabolism in Man. Washington, DC: Carnegie Institution of Washington
20. Harvie MN, Campbell IT, Baildam A, Howell A (2004) Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 83: 201-210
21. Harvie MN, Campbell IT, Thatcher N, Baildam A (2003) Changes in body composition in men and women with advanced non small cell lung cancer (NSCLC) undergoing chemotherapy. J Hum Nutr Diet 16: 323-326
22. Heasman KZ, Sutherland RN, Campbell JA, Elhakim T, Boyd NF (1985) Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat 5: 195-200
23. Hellsing K (1973) The effects of different polymers for enhancement of the antigen- antibody reaction as measured with nephelemetry in protides of the biological fluids. In Peeters H (ed) Vol 23. pp 579. Oxford: Pergamon Press
24. Herrmann VM, Garnick MB, Moore FD, Wilmore DW (1981) Effect of cytotoxic agents on protein kinetics in patients with metastatic cancer. Surgery 90: 381-387
25. Hill GL, Bradley JA, Collins JP, McCarthy I, Oxby CB, Burkinshaw L (1978) Fat free body mass from skinfold thickness: a close relationship with total body nitrogen. Br J Nutr 39: 403-405
26. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT (1991) The 5th edition of McCance & Widdowsons. The Composition of Foods. London: HMSO
27. Hyltander A, Drott C, Unsgaard B, Tolli J, Korner U, Artfvidsson B, Lundholm K (1991) The effects on body composition and exercise performance of home parenteral nutrition given as an adjunct to chemotherapy of testicular carcinoma. Eur J Clin Invest 21: 413-420
28. Jardine LG, Levin L, Gevers W (1984) Comparison of muscle and fat wasting in patients suffering from breast and other cancers: an anthropometric study. Breast Cancer Res Treat 4: 227-232
29. Jebb SA, Osborne RJ, Dixon A, Bleehen N, Elia M (1994) Measurements of resting energy expenditure and body composition before and after treatment of small-cell lung cancer. Ann Oncol 5: 915-919
30. Kajdaniuk D, Marek B (2000) Influence of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil on plasma insulin-like growth factor-I and chosen hormones in breast cancer premenopausal patients. J Clin Pharm Ther 25: 67-72
31. Karnofsky DA, Burchenel JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In Evaluation of Chemotherapeutic Agents McCleod CM (ed). pp 191-205. New York: Columbus University Press
32. Leenen R, van Der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HP (1994) Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 78: 1515-1520
33. Mahmoud FA, Rivera NI (2002) The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4: 250-255
34. McMillan DC, Scott HR, Watson WS, Preston T, Milroy R, McCardle CS (2000) Lean body mass in cancer patients with weight loss. Clin Nutr 19: 403-406
35. McMillan DC, Watson WS, Preston T, McCardle CS (1998) Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer 31: 101-105
36. Moore FD (1980) Energy and maintenance of the body cell mass. JPEN 4: 228-260
37. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21: 355-359
38. Ovesen L, Allingstrup L, Hannibal JM, Mortensen EL, Hansen OP (1993) Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomised study. J Clin Oncol 11: 2043-2049
39. Petrelli JM, Calle EE, Rodriguez C, Thun MJ (2002) Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 13: 325-332
40. Picado C, Fiz JA, Montserrat JM, Grau JM, Fernandez-Sola J, Luengo MT, Casademont J, Agusti-Vidal A (1990) Respiratory and skeletal muscle function in steroid-dependent bronchial asthma. Am Rev Respir Dis 141: 14-20
41. Rowland-Payne CM, Abbott M, Jones JM, Powles TJ, Coombes RC (1982) Weight loss during therapy for advanced breast cancer. Clin Oncol 8: 33-38
42. Russell ST, Tisdale MJ (2002) Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. Br J Cancer 87: 580-584
43. Sarna L, Lindsey AM, Dean H, Brecht ML, McCorkle R (1994) Weight change and lung cancer, relationships with symptom distress, functional status, and smoking. Res Nurs Health 17: 371-379
44. Scott HR, McMillan DC, Brown DJ, Forrest LM, McArdle CS, Milroy R (2003) A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer 40: 295-299
45. Scott HR, McMillan DC, Crilly A, McArdle CS, Milroy R (1996) The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer 73: 1560-1562
46. Simons JP, Schols AM, Buurman WA, Wouters EF (1999) Weight loss and low body cell mass in males with lung cancer, relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond) 97: 215-223
47. Smit JM, Mulder NH, Sleijfer DT, Bouman JG, Veeger W, Schraffordt Koops H (1983) The effect of continuous enteral tube feeding on various nutritional parameters in patients with disseminated malignant melanoma during intensive chemotherapy. Clin Nutr 1: 335-341
48. Staal-van den Brekel AJ, Schols AMWJ, Dentener MA, ten Velde GPM, Buurman WA, Wouters EFM. (1997b) The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small cell lung cancer. Br J Cancer 76: 1630-1635
49. Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. (1995) Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 13: 2600-2605
50. Staal-van den Brekel AJ, Schols AM, Dentener MA, ten Velde GPM, Buurman WA, Wouters EF (1997a) Metabolism in patients with small-cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls. Thorax 52: 338-341
51. Tayek JA, Chlebowski RT (1992) Metabolic response to chemotherapy. J Parenteral Enteral Nutr 16(6 Suppl): 65S-71S
52. Tisdale MJ (2001) Loss of skeletal muscle in cancer: biochemical mechanisms. Front Biosci 6: D164-D174
53. UICC (1987) Anonymous evaluation of the cancer patient and the response to treatment. In: UICC Manual of Adult and Paediatric Medical Oncology Monfardini S, Brunner K, Crowther D (eds) pp 22-38. Berlin: Springer
54. Weinstock RS, Dai H, Wadden TA (1998) Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance. Arch Intern Med 158: 2477-2483
55. Wigmore SJ, Plester CE, Ross JA, Fearon KCH (1997) Contribution of anorexia and hypermetabolism to weight loss in anorectic patients with pancreatic cancer. Br J Surg 84: 196-197
56. World health Organisation (1979) Handbook for Reporting Results for Cancer Treatment. WHO Offset Publication Vol 48. Geneva: WHO